ADVERTISEMENT



Google       
Call (866) 635-2689 for a free Personal Injury evaluation by attorney in your area.

Home -> Law Blog Directory -> Personal Injury Law Blogs -> Chicago Medical Malpractice Lawyer Blog

OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense

Find a Local Lawyer

Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402

Bookmark

Personal Injury Law

: Chicago Medical Malpractice Lawyer Blog

Merck drug drops cholesterol to new lows in study ? Discussed at the AHA Conference in Chicago

By Hurley, McKenna & Mertz

ADVERTISEMENTS

Help may be on the horizon as an experimental drug study indicates that it may offer a new way to fight heart disease. (M. Marchione, AP Medical, 11/17). The drug, anacetrapib, ?dramatically dropped bad cholesterol while boosting so-called good cholesterol to record levels.? So far, no red flags or safety issues have been recorded in tests of 1?,600 people at high risk of heart disease.?

The drug's maker, Merck & Co., says ?it will launch a much larger study to see if these changes in cholesterol lead to fewer heart attacks and strokes.? Doctors discussed these promising results at the American Heart Association conference in Chicago.

As a medical malpractice and products liability attorney in Chicago, I am intrigued by these promising results, but am, as always, hopeful that the necessary tests are complete to ensure the safety of new drugs.

Full post as published by Chicago Medical Malpractice Lawyer Blog on November 20, 2010 (boomark / email).

Bloggers, promote your law blog by nominating your blog for inclusion in USLaw.com's Law Blog Directory and RSS Reader. Benefits described.
Related Law Articles

Vioxx Lawsuits
Vioxx personal injury suits are a seroius concern for Merck and patietns

Mitchell Report Summary
Report on Steroid Drug Use in Major League Baseball by Senator George Mitchell

Lawsuits and Settlements

Drug Manufacturer Rebates
Caremark Corp. agrees to pay $38.5 million settlement after convincing doctors to switch drug brands.

Concentrated Acetaminophen Drops
Recalled by Brookstone Pharmaceuticals

Mylicon Baby's Gas Relief Drops
Urgently Recalled Nationwide

Procrit
Associated with Death in Stroke Study

Gardasil
Merck's HPV Vaccine Linked to Paralysis

Xigris
Study Prompts FDA Safety Review

Related Searches

























































































































US Law
#1 Online Legal Resource













Your Blog Subscriptions
Subscribe to blogs

10,000+ Law Job Listings
Lawyer . Police . Paralegal . Etc
Earn a law-related degree
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.


Practice Area
Zip Code:

Contact a Lawyer Now!






0.0162 secs (new cache)